Lutz Angerer, LL.M. (University of Virginia)
Socio Mercantil y Financiero
Languages
Inglés, Alemán
-
Resumen
-
Experiencia
-
Credenciales
-
Publicaciones
Lutz Angerer is an experienced down-to-earth M&A partner who is focused on pushing your M&A transactions over the finishing line, in particular in the life sciences industry where he has a wealth of knowledge and experience. He can also help you with your stock corporation law, corporate governance and corporate compliance issues and stands firm as a rock by your side when the going gets tough and you are involved in corporate litigation. Corporate reorganizations, equity capital markets transactions, capital markets law and general corporate law are also within his area of knowledge.
Lutz works out of our Munich office but is well connected in our global network. He is not only the head of our German practice group Corporate/M&A and of our German corporate compliance team, but is also co-leader of our global life sciences transactions team and member of our global life sciences industry sector team. Lutz' first case in 1993 was a life sciences case and he has worked for life sciences clients ever since. His deep and long-standing life sciences industry experience is instrumental for closing your life sciences deals successfully and the reason why he was awarded the title "Life Sciences Star" by the Legal Media Group.
Lutz started his career as a research assistant to renowned corporate law Professor Karsten Schmidt at the University of Hamburg. During this time, Lutz became a cutting-edge corporate lawyer. He is bi-cultural because he lived for more than one year in the US, has a Master of Laws from the University of Virginia and many of his clients are also from the US. Lutz is a member of the German-American Lawyers Association and of the German Corporate Law Association and publishes regularly. Among other achievements, he is co-editor and co-author of the first commentary on the German Takeover Act as well as co-author of the handbook Transatlantic Mergers and Acquisitions.
Experiencia destacada
Advising Evotec on the acquisition of the assets of Ncardia AG
Advising PerkinElmer, Inc. on its acquisition of Euroimmun Medizinische Labordiagnostika AG
Advising Ambu A/S on the acquisition of invendo medical GmbH
Advising Baxter International Inc. on the disposal of its legacy continuous renal replacement therapy business to Nikkiso by way of an asset deal in 29 countries
Advising Merck & Co., Inc. on its worldwide license agreement with AiCuris GmbH & Co. KG regarding AiCuris’s HCMV portfolio
Advising Merck & Co., Inc. on its sale of Essex Pharma Development GmbH to Adcuram Pharma Holding GmbH
Advising Merck & Co., Inc. on the integration of the Schering-Plough group into the Merck group in Germany
Advising SynCore Biotechnology Co. Ltd. on the acquistion of the EndoTAG technology from Medigene AG
Advising Lundbeck A/S on the acquisition of all rights regarding the substance Desmoteplase from Paion
Advising ZOLL Medical Corporation on the acquisition of the assets of Lifebridge Medizintechnik AG
Avising PerkinElmer, Inc. on the acquisition of chemagen Biopolymer-Technologie AG
Advising PerkinElmer, Inc. on the acquistion of Elcos AG
Advising Delticom AG on its acquisition of Tirendo group
Advising Delticom AG on its IPO
Advising Drägerwerk AG & Co. KGaA on its IPO of ordinary shares
Advising Funding Circle Holding Ltd. on its acquisition of Zencap group from Rocket Internet and others
Cartas credenciales
- Member of the German Corporate Law Association (VGR)